设计,合成,分子对接和分子动力学研究的新型quinazoline衍生物作为化酶7抑制剂
Afaf A El-Malah1, Magdy M Gineinah1, Maan T Khayat1
1Department of Pharmaceutical Chemistry, College of Pharmacy, King Abdulaziz University, Jeddah, Saudi Arabia.
Frontiers in pharmacology
|May 7, 2024
概括
新的quinazoline衍生物被合成并测试为固酶7 (PDE7) 抑制剂. 化合物4b,4g,5c和5f显示出强大的PDE7A抑制,为炎症性疾病治疗提供了一个新的策略.
科学领域:
- 药用化学 医学化学
- 酶抑制可以抑制酶.
- 药物发现 药物发现 药物发现
背景情况:
- 固酶7 (PDE7) 是一种在免疫细胞中发现的cAMP特异性酶.
- 炎症与许多疾病有关,而PDE7抑制剂可能提供治疗益处.
研究的目的:
- 设计,合成和评估新的PDE7抑制剂.
- 探索用于治疗炎症疾病的小分子抑制剂.
主要方法:
- 合成替代的4-hydrazinoquinazoline衍生物和化的三基纳.
- 在体外评估PDE7A抑制活性.
- 用于相互作用分析的分子对接和动态模拟研究.
主要成果:
- 化合物4b,4g,5c和5f显示出显著的PDE7A抑制功效.
- 分子建模支持结合相互作用,包括键和π-π堆叠.
- 合成的化合物显示出作为候选人的希望.
结论:
- 新的奇纳林衍生物有效抑制PDE7A.
- 这些发现为开发针对PDE7.7的新抗炎药物提供了基础.
更多相关视频
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.3K
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
5.0K
相关概念视频
Structure-Activity Relationships and Drug Design
701
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
701
Drug Discovery: Overview
7.8K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
7.8K
